Philip P. Waid

Characterization of LY3023414, a Novel PI3K/mTOR Dual Inhibitor Eliciting Transient Target Modulation to Impede Tumor Growth

Michèle C. Smith, Mary M. Mader, James A. Cook et al. · Molecular Cancer Therapeutics · 2016 · 74 citations

Medicine, Oncology, Pharmacology +16

Preparation of 2‐aryl and 2‐aryloxymethyl imidazo[1,2‐<i>a</i>]pyridines and related compounds

Richard J. Sundberg, Daniel J. Dahlhausen, Govindarajan Manikumar et al. · Journal of Heterocyclic Chemistry · 1988 · 48 citations

Natural Sciences, Chemistry, Medicinal Chemistry +15

Constrained amino acids. An approach to the synthesis of 3-substituted prolines

Philip P. Waid, Gary A. Flynn, Edward W. Huber et al. · Tetrahedron Letters · 1996 · 43 citations

Pharmacy, Biochemistry, Medicinal Chemistry +8

The synthesis of (1-fluorovinyl)tributyltin: A synthetic equivalent for the 1-fluoroethene anion

Donald P. Matthews, Philip P. Waid, Jeffrey S. Sabol et al. · Tetrahedron Letters · 1994 · 39 citations

Natural Sciences, Chemistry, Materials Science +3

Analogs of oxybutynin. Synthesis and antimuscarinic and bladder activity of some substituted 7-amino-1-hydroxy-5-heptyn-2-ones and related compounds

J. Paul Carter, Lalita Noronha‐Blob, Vicki H. Audia et al. · Journal of Medicinal Chemistry · 1991 · 28 citations

Medicine, Medicinal Chemistry, Pharmacology +6